Xylem XYL
$94.66 −$0.58 (-0.61%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $94.66 0.00%
Open$96.00
Prev close$95.24
Day range$94.19 – $97.57
Volume3.00M
Market cap$21.71B
P/E (TTM)21.0
Dividend yield1.79%
Fundamentals
Latest reported quarter: Q3, ended Sep 2026
Revenue$2.20B-3.0% YoY
Operating profit$393.00M+10.1% YoY
Net profit$288.00M+27.4% YoY
Diluted EPS$1.25+34.4% YoY
Free cash flow$242.00M-13.9% YoY
Operating cash flow$331.00M
Revenue, last 8 quarters
Net profit, last 8 quarters
Diluted EPS by quarter
Free cash flow by quarter
Annual revenue
Profitability & balance sheet
Gross margin39.8%
Operating margin16.1%
Net margin11.9%
Return on equity10.1%
Return on assets6.3%
Return on invested capital8.4%
Current ratio1.39
Liabilities / assets39.3%
Cash & investments$708.00M
Total debt$2.90B
Net cash (debt)-$2.19B
Free cash flow / sales10.2%
Where the revenue comes from
Quarter 2026/Q3
By business line
Income statement
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Revenue as Reported | $2.20B | $2.34B | $2.13B | $9.04B | $2.40B |
| Total Operating Revenue | $2.20B | $2.34B | $2.13B | $9.04B | $2.40B |
| Cost of Revenue | $1.29B | $1.37B | $1.32B | $5.56B | $1.47B |
| Gross Profit | $907.00M | $963.00M | $803.00M | $3.48B | $932.00M |
| Operating Expense | $514.00M | $562.00M | $528.00M | $2.15B | $546.00M |
| Selling and Admin Expenses | $458.00M | $503.00M | $472.00M | $1.92B | $486.00M |
| Research & Development | $56.00M | $59.00M | $56.00M | $226.00M | $60.00M |
| Operating Profit | $393.00M | $401.00M | $275.00M | $1.33B | $386.00M |
| Net Non-Operating Interest Income (Expense) | -$21.00M | -$7.00M | -$4.00M | -$2.00M | $21.00M |
| Non-Operating Interest Expense | $21.00M | $7.00M | $4.00M | $29.00M | $6.00M |
| Other Income (Expense) | -$7.00M | -$30.00M | -$27.00M | -$143.00M | -$39.00M |
| Special Income (Charges) | -$13.00M | -$27.00M | -$27.00M | -$134.00M | -$17.00M |
| -Less:Restructuring and Mergern & Acquisition | $8.00M | $11.00M | $30.00M | $95.00M | $33.00M |
| -Less:Write Off | $0.00 | $0.00 | $1.00M | $8.00M | $0.00 |
| -Gain on Sale Of Business | -$5.00M | -$16.00M | $4.00M | -$31.00M | $16.00M |
| Other Non-Operating Income (Expenses) | $6.00M | -$3.00M | – | -$11.00M | -$24.00M |
| Pretax Profit | $365.00M | $364.00M | $244.00M | $1.18B | $368.00M |
| Tax | $77.00M | $103.00M | $55.00M | $231.00M | $35.00M |
| Net Profit | $288.00M | $261.00M | $189.00M | $950.00M | $333.00M |
| Profit from Continuing Operations | $288.00M | $261.00M | $189.00M | $950.00M | $333.00M |
| Minority Interests | -$3.00M | -$2.00M | -$4.00M | -$7.00M | -$2.00M |
| Net Income to Parent Company | $291.00M | $263.00M | $193.00M | $957.00M | $335.00M |
| Net Income to Common Stockholders | $291.00M | $263.00M | $193.00M | $957.00M | $335.00M |
| Basic EPS | $1.25 | $1.11 | $0.79 | $3.93 | $1.37 |
| Diluted EPS | $1.25 | $1.11 | $0.79 | $3.92 | $1.37 |
| Dividend Per Share | $0.43 | $0.43 | $0.43 | $1.60 | $0.40 |
| -General & Admin Expense | – | – | $472.00M | $1.92B | – |
| Non-Operating Interest Income | – | – | – | $27.00M | – |
| Earnings from Equity Interest | – | – | – | $2.00M | – |
Balance sheet
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Assets | $17.33B | $17.34B | $16.95B | $17.63B | $17.63B |
| Total Current Assets | $3.95B | $4.39B | $4.03B | $4.64B | $4.64B |
| Cash and Cash Equivalents & Short-Term Investments | $708.00M | $1.28B | $808.00M | $1.48B | $1.48B |
| -Cash and Cash Equivalents | $708.00M | $1.28B | $808.00M | $1.48B | $1.48B |
| Receivables | $1.97B | $1.88B | $1.80B | $1.76B | $1.76B |
| -Accounts Receivable | $1.97B | $1.88B | $1.80B | $1.76B | $1.76B |
| Inventory | $1.05B | $1.02B | $991.00M | $983.00M | $983.00M |
| Other Current Assets | $227.00M | $219.00M | $243.00M | $244.00M | $244.00M |
| Total Non-Current Assets | $13.37B | $12.95B | $12.92B | $12.99B | $12.99B |
| Net PPE | $1.20B | $1.17B | $1.15B | $1.16B | $1.16B |
| Goodwill and Other Intangible Assets | $10.74B | $10.41B | $10.51B | $10.60B | $10.60B |
| -Goodwill | $8.52B | $8.26B | $8.29B | $8.33B | $8.33B |
| -Other Intangible Assets | $2.22B | $2.15B | $2.21B | $2.27B | $2.27B |
| Other Non-Current Assets | $1.43B | $1.38B | $1.27B | $1.23B | $1.23B |
| Total Liabilities | $6.82B | $6.68B | $5.73B | $5.89B | $5.89B |
| Total Current Liabilities | $2.84B | $2.72B | $2.76B | $2.86B | $2.86B |
| Payables | $1.28B | $1.21B | $1.20B | $1.22B | $1.22B |
| -Accounts Payable | $1.06B | $1.01B | $969.00M | $1.01B | $1.01B |
| -Total Tax Payable | $227.00M | $198.00M | $231.00M | $207.00M | $207.00M |
| Current Accrued Expenses | $596.00M | $544.00M | $550.00M | $538.00M | $538.00M |
| Short-Term Debt and Capital Lease Obligation | $661.00M | $660.00M | $654.00M | $655.00M | $655.00M |
| -Current Debt | $530.00M | $531.00M | $531.00M | $534.00M | $534.00M |
| -Current Capital Lease Obligation | $131.00M | $129.00M | $123.00M | $121.00M | $121.00M |
| Total Non-Current Liabilities | $3.97B | $3.95B | $2.97B | $3.03B | $3.03B |
| Non-Current Accrued Expenses | $860.00M | $810.00M | $818.00M | $899.00M | $899.00M |
| Long Term Debt and Capital Lease Obligation | $2.37B | $2.40B | $1.41B | $1.41B | $1.41B |
| -Long Term Debt | $2.37B | $2.40B | $1.41B | $1.41B | $1.41B |
| Non-Current Deferred Liabilities | $453.00M | $446.00M | $437.00M | $405.00M | $405.00M |
| Employee Benefits | $295.00M | $301.00M | $308.00M | $317.00M | $317.00M |
| Total Equity | $10.51B | $10.67B | $11.23B | $11.75B | $11.75B |
| Stockholders' Equity | $10.27B | $10.42B | $10.97B | $11.48B | $11.48B |
| Capital Stock | $3.00M | $3.00M | $3.00M | $3.00M | $3.00M |
| -Common Stock | $3.00M | $3.00M | $3.00M | $3.00M | $3.00M |
| Additional Paid-In Capital | $8.80B | $8.79B | $8.77B | $8.76B | $8.76B |
| Retained Earnings | $4.15B | $3.96B | $3.79B | $3.71B | $3.71B |
| Less: Treasury Stock | -$2.38B | -$2.02B | -$1.37B | -$768.00M | -$768.00M |
| Gains/Losses Not Affecting Retained Earnings | -$307.00M | -$302.00M | -$229.00M | -$220.00M | -$220.00M |
| Minority Interests | $242.00M | $245.00M | $257.00M | $269.00M | $269.00M |
| Other Current Liabilities | – | – | $73.00M | $72.00M | $72.00M |
| -Gross PPE | – | – | – | $2.80B | $2.80B |
| -Accumulated Depreciation | – | – | – | -$1.64B | -$1.64B |
Cash flow
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Operating Cash Flow | $331.00M | $290.00M | $108.00M | $1.24B | $543.00M |
| Net cash flow from continuing operations | $331.00M | $290.00M | $108.00M | $1.24B | $543.00M |
| Net Income from Continuing Operations | $288.00M | $261.00M | $189.00M | $950.00M | $333.00M |
| Gain/Loss from Continuing Operations | $5.00M | $16.00M | -$4.00M | $31.00M | -$16.00M |
| Depreciation & Depletion & Amortization | $137.00M | $140.00M | $140.00M | $575.00M | $143.00M |
| Other Non-Cash Items | -$7.00M | -$20.00M | -$14.00M | – | – |
| Change in Working Capital | -$106.00M | -$119.00M | -$216.00M | -$333.00M | $127.00M |
| -Change in Receivables | -$102.00M | -$157.00M | -$89.00M | -$201.00M | $20.00M |
| -Change in Inventory | -$31.00M | -$23.00M | -$18.00M | $23.00M | $53.00M |
| -Change in Payables and Accrued Expense | $56.00M | $48.00M | -$61.00M | -$91.00M | -$34.00M |
| -Change In Other Working Capital | -$29.00M | $13.00M | -$48.00M | -$64.00M | $88.00M |
| Net cash flow from investing | -$456.00M | -$22.00M | -$76.00M | -$471.00M | -$142.00M |
| Net Cash Flow from Continuing Investing Activities | -$456.00M | -$22.00M | -$76.00M | -$471.00M | -$142.00M |
| Capital Expenditure | -$89.00M | -$89.00M | -$90.00M | -$331.00M | -$83.00M |
| Net PPE Purchase and Sale | $1.00M | $10.00M | $1.00M | $17.00M | $2.00M |
| Net Business Purchase and Sale | -$389.00M | $55.00M | $0.00 | -$114.00M | -$44.00M |
| Net Investment Purchase and Sale | $20.00M | $3.00M | $14.00M | -$6.00M | -$16.00M |
| Net Other Investing Changes | $1.00M | -$1.00M | -$1.00M | -$37.00M | -$1.00M |
| Financing Cash Flow | -$451.00M | $199.00M | -$683.00M | -$501.00M | -$119.00M |
| Net Cash Flow from Continuing Financing Activities | -$451.00M | $199.00M | -$683.00M | -$501.00M | -$119.00M |
| Net Issuance Payments Of Debt | -$5.00M | $988.00M | -$4.00M | -$81.00M | -$22.00M |
| Net Common Stock Issuance | -$337.00M | -$680.00M | -$563.00M | -$15.00M | -$1.00M |
| Cash Dividends Paid | -$100.00M | -$101.00M | -$106.00M | -$391.00M | -$98.00M |
| Proceeds from Stock Option Exercised | $1.00M | $2.00M | $0.00 | $20.00M | $9.00M |
| Net Other Financing Charges | -$10.00M | -$10.00M | -$10.00M | -$34.00M | -$7.00M |
| Ending Cash Balance | $708.00M | $1.28B | $808.00M | $1.48B | $1.48B |
| Net Change in Cash | -$564.00M | $467.00M | -$651.00M | $269.00M | $271.00M |
| Beginning Cash Balance | $1.28B | $808.00M | $1.48B | $1.12B | $1.19B |
| Effect of Exchange Rate Changes | $8.00M | -$16.00M | -$15.00M | $90.00M | $7.00M |
| Free Cash Flow | $242.00M | $201.00M | $18.00M | $910.00M | $460.00M |
| Deferred Tax | – | – | – | -$35.00M | – |
No comments yet — be the first to weigh in on XYL.
Sign in to join the discussion.